Search Results - "Alezzandrini, Arturo"
-
1
INTRAVITREAL BEVACIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Results From the Pan-American Collaborative Retina Study Group (PACORES) at 24 Months of Follow-up
Published in Retina (Philadelphia, Pa.) (01-02-2017)“…To evaluate the effects of intravitreal bevacizumab (IVB) on retinal neovascularization in patients with proliferative diabetic retinopathy (PDR)…”
Get full text
Journal Article -
2
INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION: 5-Year Results of The Pan-American Collaborative Retina Study Group
Published in Retina (Philadelphia, Pa.) (01-05-2016)“…To report the long-term anatomical and functional outcomes of patients with choroidal neovascularization secondary to age-related macular degeneration treated…”
Get full text
Journal Article -
3
Early-Phase Perceptions of COVID-19’s Impact on Ophthalmology Practice Patterns: A Survey from the Pan-American Association of Ophthalmology
Published in Clinical ophthalmology (Auckland, N.Z.) (31-10-2023)“…Purpose: The COVID-19 pandemic affected medical practice worldwide due to interventions to prevent spreading. Its effect on ophthalmology practices in Latin…”
Get full text
Journal Article -
4
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema: The Pan-American Collaborative Retina Study Group at 24 Months
Published in Ophthalmology (Rochester, Minn.) (01-08-2009)“…To report the 24-month anatomic and Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) response after primary intravitreal…”
Get full text
Journal Article -
5
Non-contact wide-angled visualization with chandelier-assisted scleral buckling for primary uncomplicated rhegmatogenous retinal detachment
Published in Graefe's archive for clinical and experimental ophthalmology (01-09-2020)“…Purpose To report our experience in non-contact wide-angled visualization with chandelier-assisted scleral buckling (SB) in uncomplicated primary…”
Get full text
Journal Article -
6
Intravitreal bevacizumab for diabetic macular oedema: 5-year results of the Pan-American Collaborative Retina Study group
Published in British journal of ophthalmology (01-12-2016)“…To report the long-term anatomical and functional outcomes of patients with centre-involved diabetic macular oedema (DME) treated with intravitreal bevacizumab…”
Get more information
Journal Article -
7
Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months
Published in Retina (Philadelphia, Pa.) (01-02-2013)“…To evaluate the anatomical and functional outcomes at 24 months in patients with diffuse diabetic macular edema treated with primary intravitreal bevacizumab…”
Get full text
Journal Article -
8
New Treatment Modalities for Neovascular Age-Related Macular Degeneration
Published in Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) (01-11-2017)“…Age-related macular degeneration (AMD) is considered one of the main causes of severe vision loss in older adults. The neovascular form (nAMD) is an advanced…”
Get full text
Journal Article -
9
Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti-VEGF Intravitreal Injections: Results from the Pan-American Collaborative Retina Study (PACORES) Group
Published in Journal of ophthalmology (2021)“…Purpose. To assess the risk for capsular rupture during routine phacoemulsification in patients with a history of anti-VEGF injections and other possible risk…”
Get full text
Journal Article -
10
Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration at Twenty-four Months: The Pan-American Collaborative Retina Study
Published in Ophthalmology (Rochester, Minn.) (01-10-2010)“…Purpose To report the 24-month anatomic and Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) response after primary…”
Get full text
Journal Article -
11
A 24 month follow-up of refractory macular holes treated with an autologous transplantation of internal limiting membrane versus retina expansion technique
Published in International journal of retina and vitreous (02-10-2021)“…To compare the functional and anatomic outcomes at 24 months of eyes with a primary macular hole that failed to close after a prior surgery and were treated…”
Get full text
Journal Article -
12
Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months
Published in Retina (Philadelphia, Pa.) (01-11-2009)“…The purpose of this study was to compare the injection burden, central macular thickness (CMT), and change in best-corrected visual acuity (BCVA) after…”
Get full text
Journal Article -
13
Un-explained visual loss following silicone oil removal: results of the Pan American Collaborative Retina Study (PACORES) Group
Published in International journal of retina and vitreous (24-07-2017)“…To report the incidence and clinical features of patients that experienced un-explained visual loss following silicone oil (SO) removal. Multicenter…”
Get full text
Journal Article -
14
Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusion: results of the pan American collaborative retina study group at 24 months
Published in Retina (Philadelphia, Pa.) (01-07-2010)“…The purpose of this study was to compare the injection burden, central macular thickness (CMT), and change in best-corrected visual acuity after injecting 1.25…”
Get full text
Journal Article -
15
Intravitreal Bevacizumab (Avastin(®)) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture
Published in Current diabetes reviews (01-09-2010)“…Diabetic retinopathy (DR) remains the major threat to sight in the working age population. Diabetic macular edema (DME) is a manifestation of DR that produces…”
Get more information
Journal Article -
16
Diagnosis and current treatment of diabetic macular edema
Published in Revista de la Sociedad Argentina de Diabetes (01-09-2022)“…Diabetic macular edema is one of the leading causes of blindness in the world's population. In recent years, the scientific community has made exponential…”
Get full text
Journal Article -
17
Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy : The 2010 GLADAOF Lecture
Published in Journal of ophthalmology (01-01-2011)“…This paper demonstrates multiple benefits of intravitreal bevacizumab (IVB) on diabetic retinopathy (DR) including diabetic macular edema (DME) and…”
Get full text
Journal Article -
18
Primary Intravitreal Bevacizumab for Diffuse Diabetic Macular Edema
Published in Ophthalmology (Rochester, Minn.) (2009)“…Purpose To report the 24-month anatomic and Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) response after primary…”
Get full text
Journal Article -
19
Diagnóstico y tratamiento actual del edema macular diabético
Published in Revista de la Sociedad Argentina de Diabetes (01-09-2022)“…El edema macular diabético constituye una de las principales causas de ceguera en la población mundial. En los últimos años la comunidad científica logró…”
Get full text
Journal Article -
20
Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical Trial
Published in American journal of ophthalmology (01-11-2019)“…To assess the effectiveness and safety of an intravitreal injection of 1.25 mg bevacizumab (IVB) as a preoperative adjunct to small-gauge pars plana vitrectomy…”
Get full text
Journal Article